Stock
Novabay Pharmaceuticals Inc
Ticker not mapped · held by — managers
Reported value
—
Holders
—
Holders’ est. mark
—
Need a prior quarter
Largest holder
—
Holder count by quarter
Who holds it
Notable only| Investor | Shares | Value | Est. mark | Change |
|---|
Who left
- BlackRock, Inc.$10.3M
- GEODE CAPITAL MANAGEMENT, LLC$7.1M
- State Street$1.77M
- NORTHERN TRUST CORP$1.54M
- GOLDMAN SACHS GROUP INC$588.5K
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC$526K
- JANE STREET GROUP, LLC$395.2K
- SUSQUEHANNA INTERNATIONAL GROUP, LLP$263.6K
- C2C Wealth Management, LLC$253.8K
- Qube Research & Technologies Ltd$230.3K
- UBS Group AG$189.5K
- Apollon Wealth Management, LLC$155.4K
- Bank of New York Mellon Corp$145.5K
- OMERS ADMINISTRATION Corp$119.6K
- MORGAN STANLEY$115.8K
Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.